文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Evaluation of Chitosan Derivatives Modified Mesoporous Silica Nanoparticles as Delivery Carrier.

作者信息

Li Qi, Wang Wenqian, Hu Gaowei, Cui Xianlan, Sun Dejun, Jin Zheng, Zhao Kai

机构信息

Key Laboratory of Chemical Engineering Process and Technology for High-efficiency Conversion, College of Chemistry and Material Sciences, Heilongjiang University, Harbin 150080, China.

Institute of Nanobiomaterials and Immunology, School of Life Science, Taizhou University, Taizhou 318000, China.

出版信息

Molecules. 2021 Apr 24;26(9):2490. doi: 10.3390/molecules26092490.


DOI:10.3390/molecules26092490
PMID:33923304
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8123207/
Abstract

Chitosan is a non-toxic biological material, but chitosan is insoluble in water, which hinders the development and utilization of chitosan. Chitosan derivatives -2-Hydroxypropyl trimethyl ammonium chloride (-2-HACC) and carboxymethyl chitosan (CMCS) with good water solubility were synthesized by our laboratory. In this study, we synthesized mesoporous SiO nanoparticles by the emulsion, and then the mesoporous SiO nanoparticles were modified with γ-aminopropyltriethoxysilane to synthesize aminated mesoporous SiO nanoparticles; CMCS and -2-HACC was used to cross-link the aminated mesoporous SiO nanoparticles to construct SiO@CMCS--2-HACC nanoparticles. Because the aminated mesoporous SiO nanoparticles with positively charged can react with the mucous membranes, the virus enters the body mainly through mucous membranes, so Newcastle disease virus (NDV) was selected as the model drug to evaluate the performance of the SiO@CMCS--2-HACC nanoparticles. We prepared the SiO@CMCS--2-HACC nanoparticles loaded with inactivated NDV (NDV/SiO@CMCS--2-HACC). The SiO@CMCS--2-HACC nanoparticles as delivery carrier had high loading capacity, low cytotoxicity, good acid resistance and bile resistance and enteric solubility, and the structure of NDV protein encapsulated in the nano vaccine was not destroyed. In addition, the SiO@CMCS--2-HACC nanoparticles could sustain slowly released NDV. Therefore, the SiO@CMCS--2-HACC nanoparticles have the potential to be served as delivery vehicle for vaccine and/or drug.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42de/8123207/afa2320d7e5d/molecules-26-02490-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42de/8123207/75c48c58315f/molecules-26-02490-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42de/8123207/64a7a51f91f5/molecules-26-02490-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42de/8123207/c6eb4687abbd/molecules-26-02490-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42de/8123207/bc893c925def/molecules-26-02490-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42de/8123207/9b85148b2b2a/molecules-26-02490-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42de/8123207/e4b5f05f37fc/molecules-26-02490-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42de/8123207/50334927947e/molecules-26-02490-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42de/8123207/afa2320d7e5d/molecules-26-02490-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42de/8123207/75c48c58315f/molecules-26-02490-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42de/8123207/64a7a51f91f5/molecules-26-02490-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42de/8123207/c6eb4687abbd/molecules-26-02490-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42de/8123207/bc893c925def/molecules-26-02490-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42de/8123207/9b85148b2b2a/molecules-26-02490-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42de/8123207/e4b5f05f37fc/molecules-26-02490-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42de/8123207/50334927947e/molecules-26-02490-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42de/8123207/afa2320d7e5d/molecules-26-02490-g008.jpg

相似文献

[1]
Evaluation of Chitosan Derivatives Modified Mesoporous Silica Nanoparticles as Delivery Carrier.

Molecules. 2021-4-24

[2]
Biological evaluation of N-2-hydroxypropyl trimethyl ammonium chloride chitosan as a carrier for the delivery of live Newcastle disease vaccine.

Carbohydr Polym. 2016-4-21

[3]
O-2'-hydroxypropyltrimethyl ammonium chloride chitosan nanoparticles for the delivery of live Newcastle disease vaccine.

Carbohydr Polym. 2015-5-16

[4]
Quaternized chitosan nanoparticles loaded with the combined attenuated live vaccine against Newcastle disease and infectious bronchitis elicit immune response in chicken after intranasal administration.

Drug Deliv. 2017-11

[5]
Immune enhancement of N-2-Hydroxypropyl trimethyl ammonium chloride chitosan/carboxymethyl chitosan nanoparticles vaccine.

Int J Biol Macromol. 2022-11-1

[6]
Enhancing Mucosal Immune Response of Newcastle Disease Virus DNA Vaccine Using N-2-Hydroxypropyl Trimethylammonium Chloride Chitosan and N,O-Carboxymethyl Chitosan Nanoparticles as Delivery Carrier.

Mol Pharm. 2017-12-6

[7]
Intranasal immunization with O-2'-Hydroxypropyl trimethyl ammonium chloride chitosan nanoparticles loaded with Newcastle disease virus DNA vaccine enhances mucosal immune response in chickens.

J Nanobiotechnology. 2021-8-11

[8]
Enhanced Immune Responses to Mucosa by Functionalized Chitosan-Based Composite Nanoparticles as a Vaccine Adjuvant for Intranasal Delivery.

ACS Appl Mater Interfaces. 2022-11-30

[9]
Chitosan, hydroxypropyltrimethyl ammonium chloride chitosan and sulfated chitosan nanoparticles as adjuvants for inactivated Newcastle disease vaccine.

Carbohydr Polym. 2019-10-3

[10]
Adjuvanted quaternized chitosan composite aluminum nanoparticles-based vaccine formulation promotes immune responses in chickens.

Vaccine. 2023-5-2

引用本文的文献

[1]
Dual-Mode Antibacterial Orthodontic Composite: Contact-Killing QACs and Sustained CHX Release via Large-Pore Mesoporous Silica Nanoparticles.

Int J Mol Sci. 2025-6-26

[2]
Dansyl fluorophore functionalized hierarchically structured mesoporous silica nanoparticles as novel latent fingerprint development agents.

RSC Adv. 2024-7-17

[3]
CD44 targeted delivery of oncolytic Newcastle disease virus encapsulated in thiolated chitosan for sustained release in cervical cancer: a targeted immunotherapy approach.

Front Immunol. 2023

[4]
CD13-Mediated Pegylated Carboxymethyl Chitosan-Capped Mesoporous Silica Nanoparticles for Enhancing the Therapeutic Efficacy of Hepatocellular Carcinoma.

Pharmaceutics. 2023-1-28

[5]
Recent Advances in Mesoporous Silica Nanoparticle-Mediated Drug Delivery for Breast Cancer Treatment.

Pharmaceutics. 2023-1-9

[6]
The Potential of Chitosan in Nanomedicine: An Overview of the Cytotoxicity of Chitosan Based Nanoparticles.

Front Pharmacol. 2022-5-4

[7]
HACC-Based Nanoscale Delivery of the NbMLP28 Plasmid as a Crop Protection Strategy for Viral Diseases.

ACS Omega. 2021-11-29

[8]
Biomedical Applications of Quaternized Chitosan.

Polymers (Basel). 2021-7-30

本文引用的文献

[1]
Shape engineering boosts antibacterial activity of chitosan coated mesoporous silica nanoparticle doped with silver: a mechanistic investigation.

J Mater Chem B. 2016-5-21

[2]
Enhanced efficacy of propranolol therapy for infantile hemangiomas based on a mesoporous silica nanoplatform through mediating autophagy dysfunction.

Acta Biomater. 2020-4-15

[3]
Amino functionalized chiral mesoporous silica nanoparticles for improved loading and release of poorly water-soluble drug.

Asian J Pharm Sci. 2019-7

[4]
Crowding and confinement effects on enzyme stability in mesoporous silicas.

Int J Biol Macromol. 2019-12-5

[5]
A Responsive Mesoporous Silica Nanoparticle Platform for Magnetic Resonance Imaging-Guided High-Intensity Focused Ultrasound-Stimulated Cargo Delivery with Controllable Location, Time, and Dose.

J Am Chem Soc. 2019-10-25

[6]
New Water-Soluble Oxyamino Chitosans as Biocompatible Vectors for Efficacious Anticancer Therapy via Co-Delivery of Gene and Drug.

ACS Appl Mater Interfaces. 2019-10-7

[7]
One-step separation of the recombinant protein by using the amine-functionalized magnetic mesoporous silica nanoparticles; an efficient and facile approach.

Int J Biol Macromol. 2019-5-20

[8]
Formation of enzymatic/redox-switching nanogates on mesoporous silica nanoparticles for anticancer drug delivery.

Mater Sci Eng C Mater Biol Appl. 2019-3-9

[9]
Chitosan for gene delivery: Methods for improvement and applications.

Adv Colloid Interface Sci. 2019-3-21

[10]
Spatial, Temporal, and Dose Control of Drug Delivery using Noninvasive Magnetic Stimulation.

ACS Nano. 2019-1-18

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索